Data-Driven Decision Making

A new report from the nation's largest eye care provider boasts stellar results. We dig into the data, the industry trends, and what it means for patients.

PathAI's PathAssist Derm receives FDA Breakthrough designation, promising to enhance accuracy and speed in diagnosing the most common cancer in the U.S.

An Atlanta clinic combines lasers, biologics, and AI to challenge traditional joint surgery. Can a new marketing push make it a national alternative?

A new partnership leverages advanced AI and metabolomics to find novel drug targets for rare metabolic disorders, offering new hope for millions worldwide.

As retail crime costs Canadians billions, the RCC awards its top loss prevention leaders who are fighting back with innovation and new technology.

The trans-pacific merger between US BioTek and Australia's NutriPATH creates a major new force in functional medicine, promising expanded global access.

At MWC, Lifecycle Software unveils NEXUS® IQ, an AI platform promising to cut telco churn by 40% and transform raw customer data into profit.

Popular weight-loss drugs are linked to fewer ER visits for chronic migraine, a new study finds, sparking hope and questions about a new treatment frontier.

The industry's largest independent support provider modernizes its brand to reflect a strategic shift into a full-lifecycle ecosystem for aircraft owners.

As the spring market heats up, learn how strategic landscaping and simple maintenance can yield over 200% ROI and make your home irresistible to buyers.

French giant Efor deepens its North American footprint, acquiring CQV specialist DynamixE to target the complex cell and gene therapy manufacturing market.

The infant nutrition giant is entering Canada's booming organic market, betting on brand trust to compete in an increasingly crowded and conscious space.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?

UroGen's new bladder cancer drug sees rapid uptake post-reimbursement code, but a $153M loss and fresh debt highlight its high-stakes growth strategy.

A new dating app, QingTengZhiLian HK, promises to end swipe fatigue with psychology and AI. But can an algorithm truly engineer love in a crowded market?

Yeahka is one of only two mainland Chinese firms in its category to join S&P's elite 2026 Sustainability Yearbook, signaling a new era for ESG.

A landmark donation accelerates NUNM's campus growth, promising a new integrative medicine center to meet the soaring demand for holistic healthcare.

TomoCredit offers an AI plan to turn tax refunds into credit growth, but reporting issues and a class-action lawsuit raise questions about its effectiveness.

The global Edtech firm's prestigious accreditation signals a new era of accountability, forcing a reckoning on quality in the online tutoring market.

Scientific Beta co-founder Marc Zieger's move to QuantumStreet AI signals a major shift as AI fintechs aim to dominate institutional investing.